Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 6, 1999

View Archived Issues

Cephalon provides update on product development programs

Encouraging survival data reported for Genta's G-3139 in malignant melanoma trial

Novartis pursues development of Src kinase inhibitors for osteoporosis

New study indicates another potential indication for pentoxifylline

Inex files to begin pivotal trial of Onco TCS

Flamel Technologies to initiate phase I study of Basulin

Is depression an endocrine system disorder?

First launch for Bone Care's novel vitamin D prohormone

New cardiovascular agents from Yamanouchi block If current

Nikken Chemicals prepares PDE4 inhibitors useful for allergic and inflammatory disorders

PLA2 inhibitors remain a focus of research at Genetics Institute

Potent and selective vitronectin antagonists developed at SmithKline Beecham

CRC investigators present proof that the angiogenesis theory works in patients

Manganese chelates disclosed by Bracco, Dibra for MRI contrast imaging

P&U reports advance in the field of oxazolidinone antibacterials at ICAAC

More good news for flu drug: oseltamivir featured in JAMA article

NCI supports further study of anticancer drugs at Lorus

Acylides as new third-generation macrolide antibiotics

New tricyclic acylides exhibit improved antibacterial activity

Over 10 abstracts related to nonfluoroquinolones presented by P&G at ICAAC

Monoclonal antibodies with potential in AIDS Rx available for licensing from NIH

TAK-778, the first nonendogenous compound able to promote new bone formation and heal breaks

FDA approves new indication for Topamax

Oligo Therapeutics designs completely new class of antimicrobial agents

BioCryst's cyclopentane influenza neuraminidase inhibitors profiled: competition for Tamiflu?

FDA approves Pfizer's Tikosyn

Abgenix completes phase I/II clinical trial with ABX-IL-8

TheraTech and Procter & Gamble rework agreements for female HRT products

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...